ahlam1399
06-27-2016, 02:17 PM
REFILE-Allergy Therapeutics says study fails to find hay fever therapy dose range
June 27 (Reuters) - Drug developer Allergy Therapeutics Plc said a study on suitable doses of its therapy to treatgrass allergic rhinitis, or hay fever, did **t find arecommended dose for a...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=jLkEkU7Gy9k:lH-eSU8mbgc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=jLkEkU7Gy9k:lH-eSU8mbgc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=jLkEkU7Gy9k:lH-eSU8mbgc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=jLkEkU7Gy9k:lH-eSU8mbgc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=jLkEkU7Gy9k:lH-eSU8mbgc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/jLkEkU7Gy9k
June 27 (Reuters) - Drug developer Allergy Therapeutics Plc said a study on suitable doses of its therapy to treatgrass allergic rhinitis, or hay fever, did **t find arecommended dose for a...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=jLkEkU7Gy9k:lH-eSU8mbgc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=jLkEkU7Gy9k:lH-eSU8mbgc:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=jLkEkU7Gy9k:lH-eSU8mbgc:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=jLkEkU7Gy9k:lH-eSU8mbgc:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=jLkEkU7Gy9k:lH-eSU8mbgc:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/jLkEkU7Gy9k